This difference in OS seemed confined to patients with hormone receptor-negative/human epidermal growth factor receptor @ ( HER@ ) - negative tumors ( P = @ ) , with no differences seen with hormone receptor-positive/HER@-negative ( P = @ ) or HER@-positive tumors ( P = @ ) .